Tumor necrosis factor-α-mediated suppression of dual-specificity phosphatase 4: crosstalk between NFκB and MAPK regulates endothelial cell survival
Standard
Tumor necrosis factor-α-mediated suppression of dual-specificity phosphatase 4: crosstalk between NFκB and MAPK regulates endothelial cell survival. / Kao, Derrick D; Oldebeken, Scott R; Rai, Anjali; Lubos, Edith; Leopold, Jane A; Loscalzo, Joseph; Handy, Diane E.
in: MOL CELL BIOCHEM, Jahrgang 382, Nr. 1-2, 10.2013, S. 153-162.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Tumor necrosis factor-α-mediated suppression of dual-specificity phosphatase 4: crosstalk between NFκB and MAPK regulates endothelial cell survival
AU - Kao, Derrick D
AU - Oldebeken, Scott R
AU - Rai, Anjali
AU - Lubos, Edith
AU - Leopold, Jane A
AU - Loscalzo, Joseph
AU - Handy, Diane E
PY - 2013/10
Y1 - 2013/10
N2 - We investigated the effects of tumor necrosis factor-α (TNF-α) exposure on mitogen-activated protein kinase signaling in human microvascular endothelial cells. TNF-α caused a significant suppression of a dual specificity phosphatase, DUSP4, that regulates ERK1/2 activation. Thus, we hypothesized that suppression of DUSP4 enhances cell survival by increasing ERK1/2 signaling in response to growth factor stimulation. In support of this concept, TNF-α pre-exposure increased growth factor-mediated ERK1/2 activation, whereas overexpression of DUSP4 with an adenovirus decreased ERK1/2 compared to an empty adenovirus control. Overexpression of DUSP4 also significantly decreased cell viability, lessened recovery in an in vitro wound healing assay, and decreased DNA synthesis. Pharmacological inhibition of NFκB activation or a dominant negative construct of the inhibitor of κB significantly lessened TNF-α-mediated suppression of DUSP4 expression by 70-84% and attenuated ERK activation, implicating NFκB-dependent pathways in the TNF-α-mediated suppression of DUSP4 that contributes to ERK1/2 signaling. Taken together, our findings show that DUSP4 attenuates ERK signaling and reduces cell viability, suggesting that the novel crosstalk between NFκB and MAPK pathways contributes to cell survival.
AB - We investigated the effects of tumor necrosis factor-α (TNF-α) exposure on mitogen-activated protein kinase signaling in human microvascular endothelial cells. TNF-α caused a significant suppression of a dual specificity phosphatase, DUSP4, that regulates ERK1/2 activation. Thus, we hypothesized that suppression of DUSP4 enhances cell survival by increasing ERK1/2 signaling in response to growth factor stimulation. In support of this concept, TNF-α pre-exposure increased growth factor-mediated ERK1/2 activation, whereas overexpression of DUSP4 with an adenovirus decreased ERK1/2 compared to an empty adenovirus control. Overexpression of DUSP4 also significantly decreased cell viability, lessened recovery in an in vitro wound healing assay, and decreased DNA synthesis. Pharmacological inhibition of NFκB activation or a dominant negative construct of the inhibitor of κB significantly lessened TNF-α-mediated suppression of DUSP4 expression by 70-84% and attenuated ERK activation, implicating NFκB-dependent pathways in the TNF-α-mediated suppression of DUSP4 that contributes to ERK1/2 signaling. Taken together, our findings show that DUSP4 attenuates ERK signaling and reduces cell viability, suggesting that the novel crosstalk between NFκB and MAPK pathways contributes to cell survival.
KW - Cell Proliferation/drug effects
KW - Cell Survival/drug effects
KW - Dual-Specificity Phosphatases/antagonists & inhibitors
KW - Endothelial Cells/cytology
KW - Extracellular Signal-Regulated MAP Kinases/metabolism
KW - Humans
KW - Intercellular Signaling Peptides and Proteins/metabolism
KW - Microvessels/cytology
KW - Mitogen-Activated Protein Kinase Phosphatases/antagonists & inhibitors
KW - NF-kappa B/metabolism
KW - Signal Transduction/drug effects
KW - Tumor Necrosis Factor-alpha/pharmacology
U2 - 10.1007/s11010-013-1730-7
DO - 10.1007/s11010-013-1730-7
M3 - SCORING: Journal article
C2 - 23812841
VL - 382
SP - 153
EP - 162
JO - MOL CELL BIOCHEM
JF - MOL CELL BIOCHEM
SN - 0300-8177
IS - 1-2
ER -